Nocturnal Continuous Positive Airway Pressure (nCPAP) Decreases High-Sensitivity C-Reactive Protein (hs-CRP) in Obstructive Sleep Apnea-Hypopnea Syndrome.
Sameh MsaadAkram ChaabouniRim MarrakchiMariem BoudayaAmina KottiWalid FekiKamel JamoussiSamy KammounPublished in: Sleep disorders (2020)
nCPAP therapy may have a cardiovascular protective effect in OSAHS patients. hs-CRP level would be useful as a valuable predictor of success in OSAHS treatment monitoring.